Flexion Therapeutics Inc
FLXNDelisted Nov 19, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419600
Flexion Therapeutics Inc was delisted on Nov 19, 2021; its insiders filed their last Form 4 on Nov 23, 2021; 145 institutions reported holding it in 13F filings for Q3 2021, worth $230.4M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Flexion Therapeutics Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 145 | 4 | 1 | −140 |
| Shares | 37.7M | 1.37M | 23 | −36.3M (−100.0%) |
| Value | $230.4M | $8.33M | $0 | −$222.0M (−100.0%) |
4 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Flexion Therapeutics Inc at the end of Q4 2021 but not at the end of Q3 2021.
None.
Sold out (140)
Institutions that held Flexion Therapeutics Inc at the end of Q3 2021 and filed for Q4 2021 without it.
Showing the largest 100 of 140 by value.
Not filed for Q4 2021 yet (4)
Institutions that held Flexion Therapeutics Inc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| TPG Group Holdings (SBS) Advisors, Inc. | 936,507 | $5.71M |
| Zazove Associates LLC | 368,456 | $2.25M |
| Marshall Wace North America L.P. | 60,215 | $368.0K |
| Berman Capital Advisors, LLC | 615 | $3.00K |